No Stopping Pharma R&D as Market Predicted to Grow to $45 Bn
Antibiotics have come to underpin evolution in human healthcare - and the market is set to grow dramatically in the coming years. Increasing numbers of bacterial infections have meant demand for antibiotics has soared, whether that is treating skin infections, Urinary Tract Infections or something like tuberculosis. Infectious diseases have also been driving the need for greater pharma R&D to find new solutions to diseases such as pneumonia, malaria and lower respiratory infections. This increasing disease burden is making it...
View full press release